CAHR

Introduction The Canadian Association for Healthcare Reimbursement (CAHR) held its virtual Western Day Conference on February 9th, 2021.  Members of the MORSE team attended this conference and have prepared a brief summary of the key highlights. Disclaimer: Please note, this summary is based on our team’s interpretation of the discussion. This conference was dedicated to Steve Long, who passed away of cancer in 2019. He was a friend, mentor, and…

Introduction   The Canadian Association for Healthcare Reimbursement (CAHR) held its first virtual Market Access 201 conference on November 24, 2020.  Members of the MORSE team attended this conference and have prepared a brief summary of the key highlights. Disclaimer: Please note, this summary is based on our team’s interpretation of the discussion.   Session 1. Keynote: Evolution of HTA in United States and the Impact on International Markets  …

Panel 4: Pan-Canadian Pharmaceutical Alliance   Panel Description: This panel will focus on recent events surrounding the pCPA and how public payers believe that PMPRB reform may impact upcoming pCPA negotiations. Moderator: Sherry O’Quinn Panelists: Imran Ali, Jessica Arias and Heather McDonald Sherry O’Quinn: Our focus is on recent events around the pCPA and the pharmaceutical landscape. A lot of this discussion is framed around healthcare sustainability. Here to take…

Panel 3: Health Technology Assessment   Panel Description: Canada’s centralized HTA agency, CADTH, has recently released a new 3-year strategic plan that marks a shift from its previous vision. Noteworthy is the focus of recommendations on alignment of drug assessment with the priorities of the participating plans over all phases of the technology life cycle. Join us to hear CADTH describe their new strategic plan, how their mandate has evolved,…

Panel 2: Pharmacoeconomics   Panel Description: This panel will focus on the growing influence of pharmacoeconomics (PE) in the Canadian reimbursement process. It will discuss the implications of the revised CADTH PE guidelines on CDR and pCODR reviews. The panellists will also discuss the implications of using PE thresholds for price regulations. In addition, the impact of PE models on pCPA negotiations will also be explored. Moderator: Chris Cameron Panellists:…

Topic 1: PMPRB Panel   On Tuesday, June 13, 2017, the Canadian Association for Healthcare Reimbursement (CAHR) held its Market Access 201 conference in Toronto. The theme for this conference was Parallel or Intersecting Paths, the Future of Public and Private Reimbursement in Canada which consisted of five engaging panels focusing on key topics of interest to the Canadian pharmaceutical stakeholders. Over the coming weeks, MORSE will be releasing summaries…